Related Experiment Video
Updated: Jan 10, 2026
Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
Peroxisome Proliferator-activated Receptor Gamma Serum Levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A
Assem Mohamed Farag1, Dina El Adawy1, Amira Mohamed Noureldin Abdelrahman1
1Department of Dermatology and Venereology, Faculty of Medicine, Benha University, Banha, Egypt.
Background:
Frontal fibrosing alopecia (FFA) is a scarring alopecia with a complex pathogenesis that is not completely clear yet.
Objective:
The aims of the study were to evaluate serum peroxisome proliferator-activated receptor gamma (PPARγ) levels and gene polymorphism in a sample of Egyptian FFA patients.
Subjects And Methods:
The case-control study included 93 FFA female patients and 157 matching apparently healthy control subjects. Patients were subjected to clinical and trichoscopic examinations to diagnose FFA according to the updated diagnostic criteria. FFA severity was evaluated using the FFA Severity Index (FFASI). Serum PPARγ levels and gene polymorphisms were assessed in all participants using enzyme-linked immunosorbent assay and polymerase chain reaction techniques, respectively.
Results:
Serum PPARγ levels in the patients' group were significantly lower than that of the control subjects' group. PPARG (Pro12Ala) gene polymorphism was significantly predominant in FFA patients when compared to the control subjects. Patients carrying polymorphic genotypes showed significantly reduced serum PPARγ levels when compared to patients carrying the wild genotype. They also showed significantly higher FFASI in comparison to wild genotype carriers.
Conclusion:
PPARγ may play an important role in FFA development. It might have a potential utility as a biomarker in FFA.
